Who Classification Of Skin Tumours -

The (5th Edition, 2025) is the authoritative global standard for diagnosing and categorizing cutaneous neoplasms. Also known as the "Blue Books," this edition shifts toward a more integrated, multidisciplinary approach that combines traditional histopathology with advanced molecular genetics and immunohistochemistry. Key Structural & Conceptual Changes

This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more WHO Classification of Skin Tumours

: Each tumour entry includes clear "essential" diagnostic features and "desirable" criteria to improve diagnostic reliability worldwide. Major Clinical Updates by Category 1. Melanocytic Neoplasms The (5th Edition, 2025) is the authoritative global

: "Primary cutaneous NUT (Nuclear protein in testis) carcinoma" is included as a new provisional entity. 4. Adnexal & Soft Tissue Tumours For medical advice or diagnosis, consult a professional

: The MPATH-Dx V2.0 schema is proposed to help clinicians and pathologists communicate risk levels more effectively across four distinct classes. 2. Keratinocytic / Epidermal Tumours

: The term "variant" is now reserved strictly for genetic alterations in DNA sequences, rather than being used to describe morphological subtypes.

: This term is now used for "intermediate" lesions that exhibit borderline biological behavior but have specific molecular signatures (e.g., BAP1 inactivation or WNT pathway alterations).